Putting the award page together from the records…
Putting the award page together from the records…
Mriglobal received this contract from Nih Nci, National Institutes of Health: $21.26M obligated so far for reference laboratory testing. It runs to 2027-06-30, or to 2028-06-30 if every option is exercised.
Key facts · data as of Oct 23, 2026
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.
Cite this page: SpendQuery, Award 75N91023F00001, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_AWD_75N91023F00001_7529_75N91023D00010_7529
Mriglobal: all federal awards · Department of Health and Human Services: spending · Nih Nci: what it buys · The follow-on: recompete brief
CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT
Up for re-bid: ends 2027-06-30. Recompete brief →
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
4 subawards totaling $1.10M (5.2% of what was obligated), as Mriglobal reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| The University of Iowa | $523.4K | 1 | IA | 2026-06-24 | 2026-06-24 |
| HDT Bio Corp | $292.0K | 1 | WA | 2026-06-29 | 2026-06-29 |
| Herens Holdco S.à R.L. | $154.6K | 1 | MD | 2026-03-18 | 2026-03-18 |
| List Biological Laboratories, Inc. | $127.2K | 1 | CA | 2026-06-23 | 2026-06-23 |
| Date | To | Amount | For |
|---|---|---|---|
| 2026-06-24 | The University of Iowa | $523.4K | MANUFACTURING OF TAMOXIFEN |
| 2026-06-29 | HDT Bio Corp | $292.0K | POTENCY ASSAY DEVELOPMENT |
| 2026-03-18 | Lonza Walkersville, Inc | $154.6K | DRUG FORMULATION |
| 2026-06-23 | List Biological Laboratories, Inc. | $127.2K | STABILITY TESTING |
8 actions since 2023-06-30. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-06-24 | P00007 | Administrative change | $5.53M | CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT |
| 2025-06-03 | P00006 | Option exercised | $5.38M | CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT |
| 2025-03-04 | P00005 | Administrative change | $0 | CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT |
| 2024-10-24 | P00004 | Administrative change | $0 | CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT |
| 2024-08-30 | P00003 | Change order | $846.6K | CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT |
| 2024-06-21 | P00002 | Option exercised | $5.24M | CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT |
| 2024-06-06 | P00001 | Funding only | -$846.6K | CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT |
| 2023-06-30 | 0 | $5.10M | CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗